$98.93 +2.44 (%) Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

Jan. 27, 2015 | 04:00 PM

Partner Headlines

  1. Drugmakers Warn On Dollar

    IBD | Jan. 27, 2015 | 18:47PM EST
  2. Strong Dollar Pins U.S. Corporate Earnings Outlook

    IBD | Jan. 27, 2015 | 18:29PM EST
  3. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD | Jan. 27, 2015 | 18:10PM EST
  4. Strong Dollar Means Flabby Outlook For Some Overseas

    IBD | Jan. 27, 2015 | 13:45PM EST
  5. Bristol, Pfizer, Novartis Forecasts Face FX Pressures

    IBD | Jan. 27, 2015 | 11:57AM EST
  6. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 27, 2015 | 08:13AM EST
  7. Novartis Posts Drop In Q4 Net Profit

    Benzinga | Jan. 27, 2015 | 04:58AM EST
  8. Earnings Scheduled For January 27, 2015

    Benzinga | Jan. 27, 2015 | 04:34AM EST
  9. Lannett Early Q2 Earnings Beat Estimates; Stock Jumps

    IBD | Jan. 26, 2015 | 12:20PM EST
  10. Trio Of Wall Street Firms Up Array BioPharma Price Targets

    Benzinga | Jan. 26, 2015 | 10:05AM EST
  11. Can CAR-T Therapy Live Up To The Biotech IPO Hype?

    IBD | Jan. 26, 2015 | 08:02AM EST
  12. Benzinga's Weekend M&A Chatter

    Benzinga | Jan. 25, 2015 | 18:50PM EST
  13. Pharmaceuticals Sector To See High Voltage Action in 2015

    GuruFocus | Jan. 23, 2015 | 16:13PM EST
  14. Why Shares Of Array Biopharma Are Surging More Than 35%

    Benzinga | Jan. 23, 2015 | 11:52AM EST
  15. Johnson & Johnson Riding High On Ebola Vaccines

    GuruFocus | Jan. 21, 2015 | 11:46AM EST
  16. United Therapeutics Clears Hypertension Drug Hurdles

    IBD | Jan. 16, 2015 | 18:44PM EST
  17. Watchmakers Caught In The #Francogeddon Storm

    Benzinga | Jan. 16, 2015 | 14:39PM EST
  18. Swiss Stop Defending Franc

    IBD | Jan. 15, 2015 | 18:52PM EST
  19. 3 Reasons To Be Bullish On Generic Drug Firm Akorn

    IBD | Jan. 15, 2015 | 14:12PM EST
  20. Benzinga's Volume Movers

    Benzinga | Jan. 15, 2015 | 10:40AM EST
  21. Swiss ADRs Gain Big As Swiss National Bank Surprises With Currency Revaluation

    Benzinga | Jan. 15, 2015 | 10:07AM EST
  22. Drugs May Be Blockbusters

    IBD | Jan. 8, 2015 | 18:54PM EST
  23. Can India Stocks Top Most World Markets This Year?

    IBD | Jan. 8, 2015 | 18:29PM EST
  24. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD | Jan. 8, 2015 | 08:02AM EST
  25. US Stock Futures Jump Ahead Of Jobless Claims

    Benzinga | Jan. 8, 2015 | 07:00AM EST
  26. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD | Jan. 5, 2015 | 18:20PM EST
  27. Kite Pharma Up On Amgen Cancer Parternship

    IBD | Jan. 5, 2015 | 11:49AM EST
  28. Benzinga's Top Upgrades

    Benzinga | Jan. 5, 2015 | 08:34AM EST
  29. Cowen Upgrades Novartis To Outperform

    Benzinga | Jan. 5, 2015 | 07:01AM EST
  30. CORRECTION -- Pot Stocks Pay Off: Here's How The Marijuana Sector Fared Last Year

    Benzinga | Jan. 4, 2015 | 23:12PM EST
  31. Pot Stocks Pay Off: Here's How The Marijuana Sector Fared Last Year

    Benzinga | Jan. 4, 2015 | 21:15PM EST
  32. NeuroDerm Rebounds On Parkinson's Disease Drug Data

    IBD | Dec. 30, 2014 | 12:19PM EST
  33. Vanda rises on settlement

    IBD | Dec. 23, 2014 | 18:48PM EST
  34. Vanda Jumps After Regaining Drug Rights From Novartis

    IBD | Dec. 23, 2014 | 12:44PM EST
  35. Benzinga's Volume Movers

    Benzinga | Dec. 23, 2014 | 10:47AM EST
  36. Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Beats Expectations

    Benzinga | Dec. 23, 2014 | 10:40AM EST
  37. Morning Market Movers

    Benzinga | Dec. 23, 2014 | 09:54AM EST
  38. Stock Futures Jump On GDP Data; Walgreen, NQ Mobile Advance

    IBD | Dec. 23, 2014 | 09:10AM EST
  39. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 23, 2014 | 08:11AM EST
  40. Vanda Pharmaceuticals And Novartis Settle License Dispute

    Benzinga | Dec. 23, 2014 | 08:08AM EST
  41. Juno Therapeutics IPO Hot As Cancer Curers In Demand

    IBD | Dec. 19, 2014 | 18:32PM EST
  42. United Therapeutics Lung Drug Keeps Going And Going

    IBD | Dec. 19, 2014 | 17:20PM EST
  43. Morning Market Movers

    Benzinga | Dec. 16, 2014 | 09:42AM EST
  44. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 16, 2014 | 08:05AM EST
  45. US Stock Futures Edge Lower; Crude Oil Drops

    Benzinga | Dec. 16, 2014 | 07:03AM EST
  46. Teva Upgraded On Strength Of Copaxone MS Drug

    IBD | Dec. 12, 2014 | 10:38AM EST
  47. Novartis Reports Results of Trial Evaluating Use of Afinitor

    Benzinga | Dec. 12, 2014 | 08:34AM EST
  48. Alexandria Real Estate REIT Inks Rx For Pharma Boom

    IBD | Dec. 2, 2014 | 17:14PM EST
  49. Morgan Stanley Pair Trade On Novartis And AstraZeneca

    Benzinga | Dec. 2, 2014 | 14:01PM EST
  50. Novartis' MS drug fails trial

    IBD | Dec. 1, 2014 | 18:35PM EST
Trading Center